Unlocking the potential of immunotherapy for patients with resectable non–small cell lung cancer
Following positive results in advanced and metastatic non–small cell lung cancer (NSCLC), there has been a move toward the application of immunotherapy in the treatment of locally advanced, resectable, oncogene driver–negative disease. To date, there have been eight Phase III trials across the adjuv...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2026-01-01
|
| Serier: | Frontiers in Oncology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1690367/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
